Trials / Terminated
TerminatedNCT00489164
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions
A Randomized Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess in-stent late lumen loss in diabetic patients with de novo native coronary lesions using the sirolimus-eluting Bx VELOCITYä stent as compared to the Bx VELOCITY balloon-expandable stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sirolimus-Eluting BX Velocity Balloon-Expandable Stent |
Timeline
- Start date
- 2002-08-01
- Completion
- 2004-05-01
- First posted
- 2007-06-21
- Last updated
- 2008-11-11
Locations
11 sites across 5 countries: United States, China, India, Malaysia, Singapore
Source: ClinicalTrials.gov record NCT00489164. Inclusion in this directory is not an endorsement.